Division of Molecular Oncology and Immunology, Oncode Institute, Netherlands Cancer Institute, Amsterdam, Netherlands.
Nat Rev Cancer. 2020 Apr;20(4):218-232. doi: 10.1038/s41568-019-0235-4. Epub 2020 Feb 5.
The T cell infiltrates that are formed in human cancers are a modifier of natural disease progression and also determine the probability of clinical response to cancer immunotherapies. Recent technological advances that allow the single-cell analysis of phenotypic and transcriptional states have revealed a vast heterogeneity of intratumoural T cell states, both within and between patients, and the observation of this heterogeneity makes it critical to understand the relationship between individual T cell states and therapy response. This Review covers our current knowledge of the T cell states that are present in human tumours and the role that different T cell populations have been hypothesized to play within the tumour microenvironment, with a particular focus on CD8 T cells. The three key models that are discussed herein are as follows: (1) the dysfunction of T cells in human cancer is associated with a change in T cell functionality rather than inactivity; (2) antigen recognition in the tumour microenvironment is an important driver of T cell dysfunctionality and the presence of dysfunctional T cells can hence be used as a proxy for the presence of a tumour-reactive T cell compartment; (3) a less dysfunctional population of tumour-reactive T cells may be required to drive a durable response to T cell immune checkpoint blockade.
在人类癌症中形成的 T 细胞浸润是自然疾病进展的调节剂,也决定了癌症免疫疗法的临床反应概率。最近的技术进步允许对表型和转录状态进行单细胞分析,揭示了肿瘤内 T 细胞状态的巨大异质性,无论是在患者内部还是之间,并且观察到这种异质性使得理解个体 T 细胞状态与治疗反应之间的关系至关重要。这篇综述涵盖了我们目前对存在于人类肿瘤中的 T 细胞状态的了解,以及不同的 T 细胞群体在肿瘤微环境中被假设发挥的作用,特别关注 CD8 T 细胞。本文讨论了以下三个关键模型:(1)人类癌症中 T 细胞的功能障碍与 T 细胞功能的改变而不是不活跃有关;(2)肿瘤微环境中的抗原识别是 T 细胞功能障碍的重要驱动因素,因此功能失调的 T 细胞的存在可以作为肿瘤反应性 T 细胞区室存在的替代物;(3)需要一个功能失调程度较低的肿瘤反应性 T 细胞群体来驱动对 T 细胞免疫检查点阻断的持久反应。